Shalby Ltd

Shalby Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Shalby Ltd

₹ 216 0.84%
21 Nov - close price
shalby.org BSE: 540797 NSE: SHALBY
About

Shalby Ltd is engaged in healthcare delivery space in India. It operates a chain of multi-specialty hospitals across India. The business of the company is to offer tertiary and quaternary healthcare services to patients in various areas of specialization such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, renal transplantations, etc.[1]
The company is the global leader in knee replacement surgery and one of the top Indian hospitals in joint replacement surgery.

Key Points

Hospitals Portfolio
The co. operates 14 hospitals across India with a total bed capacity of 2,000+ beds. It also owns 60 outpatient clinics across 16 states in India and 5 OP clinics in African Countries. [1] [2] The co. has two upcoming facilities with a combined capacity of 321 beds will be located in Maharashtra. [3]

Website BSE NSE
  • Market Cap ₹ 2,330 Cr.
  • Current Price ₹ 216
  • High / Low ₹ 340 / 204
  • Stock P/E 24.5
  • Book Value ₹ 102
  • Dividend Yield 0.56 %
  • ROCE 14.1 %
  • ROE 9.72 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 25.2% CAGR over last 5 years
  • Company's working capital requirements have reduced from 55.6 days to 43.0 days

Cons

  • Company has a low return on equity of 8.84% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of BSE SmallCap BSE Healthcare BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
169 150 148 177 178 176 177 211 217 195 206 233 212
137 122 120 138 139 141 147 167 165 152 168 182 177
Operating Profit 32 28 28 39 39 35 30 45 52 43 38 50 35
OPM % 19% 19% 19% 22% 22% 20% 17% 21% 24% 22% 19% 22% 17%
3 -2 4 4 5 4 6 5 6 5 4 8 5
Interest 1 1 1 1 1 1 1 1 1 1 1 3 3
Depreciation 9 9 9 9 9 9 9 9 9 9 9 10 10
Profit before tax 25 17 23 33 34 29 26 40 47 38 33 46 28
Tax % 33% 26% 31% 35% 35% 33% 31% 35% 36% 36% 31% 34% 39%
17 13 16 21 22 19 18 26 30 25 23 30 17
EPS in Rs 1.54 1.17 1.45 1.99 2.02 1.78 1.70 2.42 2.81 2.29 2.09 2.82 1.61
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2010 Mar 2011 Mar 2014 Mar 2015 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
101 132 241 263 322 380 462 484 419 647 708 830 846
89 107 177 192 250 300 379 401 331 516 565 651 679
Operating Profit 13 25 64 70 73 80 84 83 88 131 143 179 167
OPM % 12% 19% 27% 27% 23% 21% 18% 17% 21% 20% 20% 22% 20%
1 1 3 2 6 10 9 18 9 9 20 21 23
Interest 1 0 2 5 11 12 9 7 4 4 4 4 7
Depreciation 5 5 10 20 16 22 33 36 37 36 37 37 38
Profit before tax 8 21 56 47 52 55 51 57 55 100 121 158 145
Tax % 27% 34% 26% 39% 42% 26% 37% 51% 23% 30% 33% 34%
6 14 41 28 30 40 32 28 43 70 81 104 95
EPS in Rs 2.65 5.47 11.79 8.15 3.47 3.75 2.97 2.59 3.97 6.46 7.48 9.61 8.81
Dividend Payout % -0% -0% -0% -0% -0% -0% 17% 19% 25% 15% 16% 12%
Compounded Sales Growth
10 Years: 13%
5 Years: 12%
3 Years: 26%
TTM: 8%
Compounded Profit Growth
10 Years: 9%
5 Years: 25%
3 Years: 32%
TTM: 1%
Stock Price CAGR
10 Years: %
5 Years: 14%
3 Years: 15%
1 Year: -30%
Return on Equity
10 Years: %
5 Years: 7%
3 Years: 9%
Last Year: 10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2010 Mar 2011 Mar 2014 Mar 2015 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 22 25 35 35 87 108 108 108 108 108 107 107 107
Reserves 12 23 111 137 171 657 686 706 742 799 863 955 990
4 0 37 98 325 114 71 62 44 41 34 121 115
24 19 32 77 99 96 91 105 119 139 163 192 223
Total Liabilities 62 67 215 347 682 975 956 981 1,012 1,087 1,167 1,376 1,436
33 31 105 144 312 647 689 670 658 628 603 599 589
CWIP -0 0 5 91 221 47 3 6 8 6 10 5 6
Investments 4 6 19 26 10 10 24 43 32 62 313 511 542
25 30 86 86 139 270 239 262 315 391 242 260 299
Total Assets 62 67 215 347 682 975 956 981 1,012 1,087 1,167 1,376 1,436

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2010 Mar 2011 Mar 2014 Mar 2015 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
9 7 71 15 46 57 77 101 165 140
-6 -5 -157 -241 -0 -32 -52 -40 -172 -206
1 -3 89 226 -51 -22 -28 -17 -38 72
Net Cash Flow 3 -1 3 -1 -6 3 -2 43 -46 6

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2010 Mar 2011 Mar 2014 Mar 2015 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 34 25 21 28 38 48 64 69 81 53 46 52
Inventory Days
Days Payable
Cash Conversion Cycle 34 25 21 28 38 48 64 69 81 53 46 52
Working Capital Days -19 16 41 -60 -28 0 61 73 87 82 41 43
ROCE % 48% 23% 9% 7% 7% 7% 12% 13% 14%

Shareholding Pattern

Numbers in percentages

1 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
74.02% 74.02% 74.04% 74.04% 74.12% 74.12% 74.12% 74.12% 74.12% 74.24% 74.25% 74.25%
3.83% 3.95% 3.92% 3.78% 3.97% 3.92% 4.00% 4.11% 4.62% 4.88% 5.35% 5.37%
0.00% 0.00% 0.00% 0.28% 0.06% 0.00% 0.00% 0.00% 0.00% 0.00% 0.06% 0.09%
21.22% 21.10% 21.12% 20.97% 20.97% 21.09% 21.00% 20.90% 20.42% 20.13% 19.65% 19.59%
0.93% 0.93% 0.93% 0.93% 0.87% 0.87% 0.87% 0.87% 0.83% 0.76% 0.70% 0.69%
No. of Shareholders 55,56255,23354,66654,53752,77552,18152,58050,22549,49549,85849,31551,479

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls